Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Anti-Plasmodium Antibodies And Methods Of Use

  • Read more about Anti-Plasmodium Antibodies And Methods Of Use
US Application 60/122,842
Filed on 1999-03-04

Compounds and Methods for Restricting HIV-1 Replication in CD4+ Lymphocytes

  • Read more about Compounds and Methods for Restricting HIV-1 Replication in CD4+ Lymphocytes
US Application 60/523,683
Filed on 2003-11-21

Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein

  • Read more about Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
US Application 60/496,660
Filed on 2003-08-21

Mechanisms For Improving The Breadth Of The Immune Response To Diverse Strains And Clades For HIV

  • Read more about Mechanisms For Improving The Breadth Of The Immune Response To Diverse Strains And Clades For HIV
US Application 60/503,509
Filed on 2003-09-15

Reagents And Approaches Relevant To The Diagnosis, Vaccinationa And Treatment Of SARS And Analysis Fo The Immune Response.

  • Read more about Reagents And Approaches Relevant To The Diagnosis, Vaccinationa And Treatment Of SARS And Analysis Fo The Immune Response.
US Application 60/503,508
Filed on 2003-09-15

Streptococcus Lipoprotein Antigens

  • Read more about Streptococcus Lipoprotein Antigens
US Application 60/519,028
Filed on 2003-11-10

Plasmodium Vivax Transporter Responsible For Chloroquine Resistance In Human Malaria

  • Read more about Plasmodium Vivax Transporter Responsible For Chloroquine Resistance In Human Malaria
US Application 60/153,197
Filed on 1999-09-10

Accelerated Vaccination

  • Read more about Accelerated Vaccination
US Application 60/491,933
Filed on 2003-08-01

Use Of Statin to Kill EBV-Transformed B Cells

  • Read more about Use Of Statin to Kill EBV-Transformed B Cells
US Application 60/515,013
Filed on 2003-10-28

Enhancing The Structure Of Soluble HIV-1 Envelope Protein For Use As A Vaccine Component

  • Read more about Enhancing The Structure Of Soluble HIV-1 Envelope Protein For Use As A Vaccine Component
US Application 60/510,952
Filed on 2003-10-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • Page 99
  • Page 100
  • Page 101
  • Page 102
  • Page 103
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health